Invivogen
Menu

Recombinant human CD40L protein - Bioactive cytokine

Product Unit size Cat. code Docs. Qty. Price

Recombinant human CD40L

Recombinant Cytokine, source: E. coli

Show product

10 µg

5 x 10µg

rcyec-hcd40l
+-
$161

Human CD40L protein - Mammalian cell-expressed, tag-free, with HSA

Recombinant human CD40L is a high-quality and biologically active cytokine, validated using proprietary CD40L reporter cells. This member of the TNF superfamily is produced in E. coli and thoroughly purified to remove endotoxins.

Recombinant human CD40L can be used together with HEK-Blue™ CD40L cells for the screening of inhibitory molecules, such as Frexalimab, a monoclonal antibody targeting CD40L (see figures).

CD40L signaling and biological functions
CD40L signaling and biological functions

InvivoGen also offers:

HEK-Blue™ CD40L cells

 

Key features

  • Each lot is validated using HEK-Blue™ CD40L cells
  • Endotoxin < 0.1 EU/µg
  • 0.2 µm sterile-filtered

Applications

  • Standard for CD40L detection and quantification assays
  • Screening and release assays for antibodies blocking CD40L signaling
  • Screening and release assays for engineered CD40L

 

CD40 Ligand (CD40L) is a protein that is primarily expressed on activated T cells and is a member of the tumor necrosis factor superfamily. Of note, CD40L, together with its receptor CD40, plays a pivotal role in cellular and humoral immunity.

 More details

 

InvivoGen’s products are for research use only, and not for clinical or veterinary use.

Figures

Detection by SDS-PAGE
Detection by SDS-PAGE

SDS PAGE of the recombinant human (h)CD40L protein. 1.5 μg of hCD40L was loaded on a 12% Mini-PROTEAN® TGX StainFree™ Precast Gel (Bio-Rad). Detection was performed as per the manufacturer’s instructions. A band was detected at ~16 kDa.

Dose-response in HEK-Blue™ CD40 cells to recombinant hCD40L cytokine
Dose-response in HEK-Blue™ CD40 cells to recombinant hCD40L cytokine

Dose-response in HEK-Blue™ CD40 cells to recombinant hCD40L protein. Cells were stimulated with increasing concentrations of recombinant human (h)CD40L. After overnight incubation, the NF-κB-induced SEAP activity was determined using QUANTI-Blue™, a SEAP detection reagent. Data are shown as optical density (OD) at 650 nm (mean ± SEM).

Back to the top

Specifications

Source: E. coli

Species: Human

Alternative names: CD154, T-cell antigen Gp39, TNF-related activation protein (TRAP), Tumor necrosis factor ligand superfamily member 5

Carrier: HSA (human serum albumin)

Tag: Tag-free

Accession number: P29965

Molecular weight: ~ 16 kDa (SDS-PAGE)

Solubility: 100 μg/ml in water

Formulation: Phosphate buffer saline (pH 7.4), 5% saccharose, 2% HSA

Sterility: 0.2 µm filtration

Form: Lyophilized

Reconstitution buffer: Endotoxin-free water (provided)

Purity: ≥95% (SDS-PAGE)

Endotoxin level: ≤ 0.1 EU/μg (measurement by kinetic chromogenic LAL assay)

Tested applications: Cellular assays

Quality control: Each lot is functionally tested and validated.

Back to the top

Contents

Recombinant human CD40L is provided as a lyophilized powder and is available in two quantities:

  • rcyec-hcd40l: 10 μg
  • rcyec-hcd40l-5: 50 μg (5 x 10 μg)
  • 1.5 ml endotoxin-free water for rcyec-hcd40l and rcyec-hcd40l-5

room temperature Recombinant human CD40L is shipped at room temperature.

store Upon receipt, the product should be stored at -20 °C.

Alert Avoid repeated freeze-thaw cycles.

Back to the top

Details

CD40 Ligand (CD40L), also known as CD154, TRAP, or gp39, is a type II transmembrane glycoprotein belonging to the tumor necrosis factor (TNF) family. It is mainly expressed in CD4+-T cells and interacts with CD40 on antigen-presenting cells to regulate both humoral and cellular immune responses [1-3].

The CD40 cytoplasmic domain binds directly to several TNF receptor-associated factors (TRAFs), and this interaction is thought to initiate CD40 signaling. CD40-mediated signaling results in NF-κB, c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (MAPK) activation. CD40L-CD40 interactions are thought to play an important role in the pathogenesis of many diseases [4, 5].

 

1. Karnell J.L. et al., 2019. Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond. Adv Drug Deliv Rev. 141:92-103.
2. Laman J.D. et al., 2017. Functions of CD40 and Its Ligand, gp39 (CD40L). Crit Rev Immunol. 37(2-6):371-420.
3. Elgueta R. et al., 2009. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 229, 152–172.
4. Seijkens T. et al., 2013. CD40–CD40L: Linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications. Diabetes and Vascular Disease Research. 10: 115-122.
5. Daoussis D. et al., 2004. Targeting CD40L: a promising therapeutic approach. Clin Diagn Lab Immunol. 11(4):635-41.

Back to the top
Customer Service
& Technical Support
Shopping cart is empty